Tetsuro Matano Selected Research

Tetsuro Matano Research Topics

Disease

29	Infections 07/2022 - 09/2003
16	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 09/2003
11	HIV Infections (HIV Infection) 01/2022 - 06/2007
10	Virus Diseases (Viral Diseases) 01/2022 - 06/2002
7	COVID-19 01/2022 - 01/2021
5	Viremia 01/2022 - 04/2012
3	Disease Progression 01/2022 - 05/2007
2	Inflammation (Inflammations) 01/2022 - 01/2021
2	Persistent Infection 05/2010 - 12/2007
1	Bacillary Dysentery (Shigellosis) 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Dysbiosis 01/2021
1	Diarrhea 01/2021
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 05/2020
1	Chronic Disease (Chronic Diseases) 06/2004

Drug/Important Bio-Agent (IBA)

19	VaccinesIBA 01/2022 - 09/2003
11	Neutralizing AntibodiesIBA 01/2022 - 06/2007
7	AntibodiesIBA 01/2022 - 06/2007
7	EpitopesIBA 01/2022 - 03/2008
6	AIDS VaccinesIBA 11/2015 - 09/2003
4	Biomarkers (Surrogate Marker)IBA 07/2022 - 12/2019
4	CytokinesIBA 01/2022 - 01/2021
4	Antiviral Agents (Antivirals)IBA 04/2021 - 06/2007
4	AntigensIBA 01/2016 - 06/2002
2	16S Ribosomal RNAIBA 01/2022 - 01/2021
2	HLA-B57 antigenIBA 01/2022 - 01/2020
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 11/2019
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2022 - 07/2014
2	HLA-A Antigens (HLA-A)IBA 01/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 10/2021 - 01/2021
2	Aspartic Acid (Aspartate)FDA Link 10/2010 - 03/2008
2	Glutamic Acid (Glutamate)FDA Link 10/2010 - 03/2008
2	DNA (Deoxyribonucleic Acid)IBA 04/2010 - 09/2003
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Polysaccharides (Glycans)IBA 01/2022
1	Norfloxacin FDA Link 01/2022
1	HLA-B Antigens (HLA-B)IBA 01/2022
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2022
1	InterferonsIBA 01/2022
1	Sialic AcidsIBA 01/2022
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2022
1	A-factor (Streptomyces)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2021
1	Viral RNAIBA 01/2021
1	ChemokinesIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Viral AntigensIBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	SAIDS VaccinesIBA 09/2016
1	gag Gene Products (gag Protein)IBA 01/2016
1	interleukin-21 (interleukin 21)IBA 09/2013
1	Histocompatibility Antigens Class IIBA 11/2011

Therapy/Procedure

4	Therapeutics 01/2022 - 09/2016
1	Art Therapy 01/2021
1	Isogeneic Transplantation 05/2020
1	Highly Active Antiretroviral Therapy (HAART) 04/2012